Skip to main content
CMG Pharmaceutical Co., Ltd. logo

CMG Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 058820 ISIN · KR7058820002 KO Manufacturing
Open in API
Filings indexed 165 across all filing types
Latest filing 2022-05-16 Report Publication Anno…
Country KR South Korea
Listing KO 058820

About CMG Pharmaceutical Co., Ltd.

http://www.cmgpharma.co.kr

CMG Pharmaceutical Co., Ltd. is a pharmaceutical company specializing in the development of advanced drug delivery systems. The company's core competency is its Oral Thin Film (OTF), or Orally Dissolving Film (ODF), technology platform. This technology is used to develop improved new drugs, new formulations, and combination therapies designed to enhance patient convenience and efficacy. The company's portfolio includes prescription medications and general pharmaceuticals. As an affiliate of CHA Health Systems, CMG Pharmaceutical is actively engaged in research and development, managing a pipeline of drug candidates and conducting clinical trials.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) event (기업설명회). It provides the date, time, location (Zoom), and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it is a short regulatory notice, it falls under the category of a Report Publication Announcement or general regulatory filing regarding corporate events.
2022-05-16 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for CMG Pharmaceutical Co., Ltd. (주식회사 CMG제약) covering the period from January 1, 2022, to March 31, 2022. It contains detailed financial statements, management discussion and analysis, and operational data, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-13 Korean
소속부변경
Regulatory Filings Classification · 100% confidence The document is a short, formal notification regarding a change in the company's market classification (from 'Large-cap' to 'Mid-cap' enterprise division) on the stock exchange. It does not contain financial statements, management discussions, or other substantive reports. As it is a regulatory notification of a corporate status change that does not fit into specific categories like M&A or share issues, it falls under the general regulatory filing category.
2022-04-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides the official outcomes of the shareholder meeting held on March 25, 2022, including the approval of financial statements, director/auditor compensation limits, and other agenda items. This fits the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-03-25 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal announcement titled 'Audit Report Submission' (감사보고서 제출) from CMG Pharmaceutical. It provides a summary of the audit opinion (unqualified/proper) and key financial data (assets, liabilities, profit/loss) for the fiscal year. While it contains financial data, it is a regulatory notification of the audit report's completion and filing, rather than the full annual report (10-K) or a standalone audit report document. Given the structure and the specific regulatory filing nature, it fits the 'Audit Report / Information' (AR) category as it reports the results of the audit process. FY 2021
2022-03-17 Korean
사업보고서 (2021.12)
Annual Report Classification · 100% confidence The document is a '사업보고서' (Business Report) for CMG Pharmaceutical, covering the fiscal year 2021 (Jan 1, 2021 to Dec 31, 2021). It contains comprehensive financial statements, management discussion and analysis, governance details, and operational data. In the South Korean regulatory context, a '사업보고서' is the equivalent of an Annual Report (10-K). FY 2021
2022-03-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.